First human trial launches for new targeted cancer drug
NCT ID NCT06884618
Summary
This is an early-stage study to find a safe dose of a new drug called RO7673396 for people with advanced solid tumors that have a specific genetic change called a RAS mutation. The study will first test increasing doses to see what is safe, then test that dose to see if it helps shrink tumors. It is for people whose cancer has spread or returned and cannot be cured with standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Comprehensive Cancer Center
RECRUITINGDuarte, California, 91010, United States
-
Florida Cancer Specialists - Sarasota (North Catttlemen Rd)
RECRUITINGSarasota, Florida, 34232, United States
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 201315, China
-
Hubei Cancer Hospital
RECRUITINGWuhan, 430079, China
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-3721, United States
-
National Cancer Centre - 30 Hospital Blvd
RECRUITINGSingapore, 168583, Singapore
-
National Cheng Kung University Hospital
RECRUITINGTainan, 70403, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, 10002, Taiwan
-
New Zealand Clinical Research - Auckland
RECRUITINGAuckland, 1010, New Zealand
-
New Zealand Clinical Research - Christchurch
RECRUITINGChristchurch, 8011, New Zealand
-
Peter MacCallum Cancer Center
RECRUITINGParkville, Victoria, 3052, Australia
-
Prince of Wales Hospital
RECRUITINGHong Kong, Hong Kong
-
Princess Margaret Hospital
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Smilow Cancer Hospital at Yale New Haven
RECRUITINGNew Haven, Connecticut, 06519-1110, United States
-
South Texas Accelerated Research Therapeutics (START)
RECRUITINGSan Antonio, Texas, 78229-4427, United States
-
St Vincent's Hospital Sydney
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
-
Sun Yat-Sen University Cancer Center - Huangpu Campus
RECRUITINGGuangzhou, Guangdong, 510555, China
-
Sun Yat-Sen University Cancer Center;Department of Thoracic Surgery
RECRUITINGGuangzhou, 510050, China
-
University of Colorado - Anschutz Medical Campus - PPDS
RECRUITINGAurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.